NEW YORK (AP) - European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system. Eliquis was approved for use in the 27 European Union countries in patients at risk for such clots, called systemic embolisms, or for strokes who have...
more »